Cabozantinib has shown promising activity for the treatment of various sarcomas, supporting further evaluation in this setting.
No takes yet. Share an insight, caveat, or question.
Schöffski et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: